Virax Biolabs Group Ltd
VRAX· Nasdaq
VRAXVirax Biolabs Group Ltd
Who holds Virax Biolabs Group Ltd, from the managers’ Form 13F reports for the quarter ended Jun 30, 2026.
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| Jane Street Group, LLC | 26.4K | New | $77.6K | 0% | Aug 14, 2026 |
| UBS Group AG | 4 | New | $12 | 0% | Aug 13, 2026 |
